Innovid Corp.
CTV · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $140 | $127 | $90 | $69 |
| % Growth | 10% | 40.8% | 31.2% | – |
| Cost of Goods Sold | $34 | $30 | $18 | $12 |
| Gross Profit | $106 | $97 | $73 | $56 |
| % Margin | 75.8% | 76.3% | 80.3% | 82% |
| R&D Expenses | $27 | $31 | $25 | $18 |
| G&A Expenses | $39 | $39 | $21 | $8 |
| SG&A Expenses | $85 | $89 | $54 | $37 |
| Sales & Mktg Exp. | $46 | $50 | $33 | $29 |
| Other Operating Expenses | $0 | $6 | $0 | $0 |
| Operating Expenses | $112 | $127 | $78 | $55 |
| Operating Income | -$16 | -$30 | -$6 | $1 |
| % Margin | -11.5% | -23.4% | -6.5% | 1.6% |
| Other Income/Exp. Net | -$13 | $13 | -$4 | -$1 |
| Pre-Tax Income | -$30 | -$16 | -$10 | $0 |
| Tax Expense | $2 | $2 | $1 | $1 |
| Net Income | -$32 | -$18 | -$11 | -$1 |
| % Margin | -22.8% | -14.5% | -12.7% | -1.2% |
| EPS | -0.23 | -0.14 | -0.094 | -0.051 |
| % Growth | -64.3% | -48.5% | -86% | – |
| EPS Diluted | -0.23 | -0.14 | -0.094 | -0.051 |
| Weighted Avg Shares Out | 139 | 131 | 122 | 16 |
| Weighted Avg Shares Out Dil | 139 | 131 | 122 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $13 | $0 | $0 |
| Interest Expense | $0 | $0 | $4 | $1 |
| Depreciation & Amortization | $13 | $6 | $1 | $1 |
| EBITDA | -$5 | -$24 | -$5 | $2 |
| % Margin | -3.9% | -19% | -5.7% | 2.7% |